CHINA MED Stock

CHME

US1694911074

Pharmaceuticals

Market Closed - OTC Markets 12:29:20 2025-12-30 EST			5-day change	1st Jan Change
0.0300 ^USD	+30.43%		-.--%	-

China Medicine Corp is a pharmaceutical company. The Company is engaged in the production and distribution of prescription and over the counter (OTC) drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The Company is developing a number of products for a range of indications, including oncology, high blood pressure and the removal of toxins from food and animal feeds. The Company's products include Shuangdan Capsules, Houerhuan Anti-inflammatory Capsules, Shugan Yipi Granules, Danggui Tiaojing Granules, Huangzao Granules, Pingfeng Shengmai Capsules, Danqi Tablets and Naodesheng Tablets. The Company also offers a range of dietary supplements, which include BeThin Tablets, Refrelizer Herbal Tea, LifeFull Herbal Tea and Relaxetox Herbal Tea. Shuangdan Capsules are indicated for the treatment of stagnation of the heart blood, obstruction of qi in the chest and cardiodynia.

Employees

Sector

Pharmaceuticals

More about the company

Stock Market
Stocks
CHME Stock

-40%: Exceptional extension

SEIZE THE OFFER!

11-03-23	CHINA MED : China Medicine Corporation Files Extension for Fiscal 2010 Form 10-K Filing	PR
11-03-23	CHINA MED : China Medicine Corporation Voluntarily Withdraws Application for Nasdaq Listing	PR
11-03-03	CHINA MED : China Medicine Corporation Adopts New Incentive Compensation Plans	PR
11-02-22	CHINA MED : China Medicine Corporation Announces Auditor Will Decline to Stand for Re-Appointment	PR
11-02-01	CHINA MED : China Medicine Corporation Receives Manufacturing License for rADTZ	PR

3 years	0		0.04
5 years	0		0.04
10 years	0		0.2

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CHINA MED	+30.43%	-.--%	-	-	0
ELI LILLY AND COMPANY	+0.45%	+3.00%	+55.00%	+112.54%	1,043B
JOHNSON & JOHNSON	-0.10%	+0.74%	+54.52%	+67.72%	649B
ABBVIE INC.	+0.28%	+0.82%	+19.15%	+73.63%	469B
ROCHE HOLDING AG	+0.22%	+0.47%	+37.33%	+45.94%	355B
NOVARTIS AG	+0.35%	+2.03%	+19.57%	+26.05%	270B
ASTRAZENECA PLC	-0.41%	+3.84%	+11.94%	+12.58%	262B
AMGEN INC.	+4.34%	+9.21%	+43.44%	+53.25%	222B
GILEAD SCIENCES, INC.	+1.40%	+4.35%	+35.72%	+103.53%	189B
NOVO NORDISK A/S	-0.25%	-5.41%	-31.14%	-59.53%	175B
Average	+3.64%	+1.98%	+27.28%	+48.41%	363.3B
Weighted average by Cap.	+0.45%	+2.19%	+36.96%	+67.00%

CHINA MED Stock

Stocks

CHME

US1694911074

Pharmaceuticals

Chart: CHINA MED

Press Releases: CHINA MED

Price Extremes

Managers and Directors: CHINA MED

Other Pharmaceuticals

Company Profile